Efficacy and safety of enzalutamide versus bicalutamide for patients with metastatic prostate cancer (TERRAIN): a randomised, double-blind, phase 2 study. [electronic resource]
Producer: 20160628Description: 153-163 p. digitalISSN:- 1474-5488
- Aged
- Aged, 80 and over
- Anemia -- chemically induced
- Anilides -- adverse effects
- Arthralgia -- chemically induced
- Back Pain -- chemically induced
- Benzamides
- Constipation -- chemically induced
- Disease Progression
- Disease-Free Survival
- Double-Blind Method
- Dyspnea -- chemically induced
- Fatigue -- chemically induced
- Fractures, Spontaneous -- chemically induced
- Heart Failure -- chemically induced
- Hot Flashes -- chemically induced
- Humans
- Hydronephrosis -- chemically induced
- Hypertension -- chemically induced
- Male
- Middle Aged
- Myocardial Infarction -- chemically induced
- Nausea -- chemically induced
- Nitriles -- adverse effects
- Patient Dropouts
- Phenylthiohydantoin -- adverse effects
- Prostatic Neoplasms, Castration-Resistant -- drug therapy
- Tosyl Compounds -- adverse effects
No physical items for this record
Publication Type: Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.